share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer GONZALEZ RICHARD A

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer GONZALEZ RICHARD A

艾伯维公司 | 4:持股变动声明-高管 GONZALEZ RICHARD A
美股SEC公告 ·  08/07 17:02

Moomoo AI 已提取核心信息

Richard A. Gonzalez, Executive Chairman of the Board at AbbVie Inc. [ABBV], completed a sale of 66,500 shares of common stock on August 5, 2024. The transaction was carried out in the open market with the shares sold at a price of $186.52 each, resulting in a total market value of $12,403,580. Following the sale, Gonzalez directly holds 446,599 shares of AbbVie's common stock.
Richard A. Gonzalez, Executive Chairman of the Board at AbbVie Inc. [ABBV], completed a sale of 66,500 shares of common stock on August 5, 2024. The transaction was carried out in the open market with the shares sold at a price of $186.52 each, resulting in a total market value of $12,403,580. Following the sale, Gonzalez directly holds 446,599 shares of AbbVie's common stock.
艾伯维公司董事会执行主席Richard A. Gonzalez于2024年8月5日完成了一笔共计66,500股普通股的交易。此交易在公开市场进行,每股售价为186.52美元,总市值为12,403,580美元。出售后,Gonzalez直接持有446,599股艾伯维公司的普通股。
艾伯维公司董事会执行主席Richard A. Gonzalez于2024年8月5日完成了一笔共计66,500股普通股的交易。此交易在公开市场进行,每股售价为186.52美元,总市值为12,403,580美元。出售后,Gonzalez直接持有446,599股艾伯维公司的普通股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息